Three Biotechs That Takeover: Top 2026 M&A Targets
As large pharma hunts for GLP-1 and cardiovascular assets, three biotechs stand out as hot takeover targets. This rep...
This quick guide explains typical candidates for credit builder loans and the situations where they can be most effective in building credit.
24,219 articlesAs large pharma hunts for GLP-1 and cardiovascular assets, three biotechs stand out as hot takeover targets. This rep...
In a choppy 2026 market, a momentum-focused ETF is gaining attention for its track record of catching leaders while a...
Investor sentiment shifted on a day when Poet Technologies announced a large equity offering. This piece explains wha...
Get an in-depth look at Paysafe (PSFE) 2026 earnings outlook. We break down Q1 results, revenue streams, margin trend...
Speculative AI-driven forecasts tied to Sam Altman's tools predict altman chatgpt predicts incredible upside for DOGE...
NVIDIA has stunned investors with a dramatic dividend move and a massive buyback. This article breaks down what it me...
Gas prices hover near fresh highs as families hit the road for the summer travel rush. A simple trio—drive slower, el...
Palantir stock has fallen from its all-time high, but a fall doesn’t mean a free pass to buy. This guide breaks down ...
A year of blistering gains can blur rational thinking. This infrastructure stock 570% rally prompts a careful plan: s...
When a flagship endowment changes its crypto holdings, it offers a rare peek into risk management. This guide breaks ...
The Vatican issues Magnifica Humanitas, a landmark call for AI regulation and human-centric design. Anthropic partici...
Security researchers warn that the next DeFi exploit will likely begin in the developer supply chain, exploiting pack...